When Norman Shapiro, a sweet wirehaired Dachshund mix, was first brought in after his groomer noticed something didn’t feel quite right, his family had no idea how complex his journey would become, or how much strength this little dog had in him.

Norman was diagnosed with apocrine gland anal sac adenocarcinoma (AGASACA), a rare but aggressive cancer that arises from the anal glands and has a tendency to spread to nearby lymph nodes. While frightening to hear, Norman’s story is one of early detection, advanced diagnostics, collaborative care, and, most importantly, perseverance.

Step One: Diagnosis and Surgery

Norman’s primary tumor was surgically removed, and pathology confirmed AGASACA with clean margins. While this was encouraging, this type of cancer is known for its potential to spread, even when the original mass is successfully excised. Because of this, Norman was referred to our oncology team for further staging and guidance.

Under the care of our board-certified oncologist, Dr. Katilee Jacobs, advanced imaging was recommended to look for any signs of cancer elsewhere in the body. A CT scan of Norman’s chest and abdomen revealed enlarged lymph nodes deep within the abdomen, a finding concerning for metastatic spread.

A Multidisciplinary Plan

Given these findings, a comprehensive, team-based treatment plan was developed. Norman underwent abdominal surgery with our board-certified surgeon, Dr. Kim Aeschlimann, to remove the affected lymph nodes. During the same procedure, his gallbladder, which was found to contain stones and early disease, was also removed to prevent future complications.

Norman’s surgery was complex, and his recovery required close monitoring and supportive care. Complications such as temporary urinary issues and pancreatitis arose, but with attentive hospitalization, advanced imaging, pain management, and coordinated care, Norman steadily improved.

Throughout this time, our internal medicine specialist, Dr. Alex Portanova, played a key role in managing Norman’s gastrointestinal health, urinary healing, and overall medical stability.

Chemotherapy: Adjusting the Plan for the Patient

Once Norman had recovered enough from surgery, the next step was chemotherapy with carboplatin, a medication commonly used to slow cancer progression in cases like his.

Norman’s first treatment was tough. He experienced gastrointestinal side effects and decreased appetite, something no one wants to see in a beloved pet. But Norman’s care team and family didn’t give up. With dose adjustments, additional supportive medications, and careful monitoring, Norman began to tolerate treatment much better.

A Big Milestone

On Wednesday, February 4, Norman reached a major milestone: he officially graduated from chemotherapy.

Today, Norman is doing wonderfully. He’s bright, comfortable, eating well, and enjoying life at home with his family. While ongoing monitoring will always be part of his journey, his story is a powerful reminder that even with a serious diagnosis, pets can continue to have an excellent quality of life with the right care.

The Power of Team-Based Care

Norman’s journey highlights what is possible when specialists work together seamlessly. From oncology and surgery to internal medicine and supportive nursing care, every step of his treatment was guided by collaboration, communication, and compassion.

At Overland Park Veterinary Emergency and Specialty, our goal is never just to treat disease; it’s to support the whole patient and the family who loves them.